Legal Representation
Attorney
Kumiko Ide
USPTO Deadlines
Next Deadline
1968 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250513)
Due Date
May 13, 2031
Grace Period Ends
November 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 13, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 13, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 22, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 22, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 12, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 10, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 10, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 3, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 18, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 3, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 20, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 18, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 18, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 28, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 3, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 3, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 13, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 28, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 17, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 11, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 11, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 11, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 11, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 2, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 2, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 2, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 10, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Mar 10, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Dec 13, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 13, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 13, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 8, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 28, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Mar 17, 2022 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Mar 10, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 10, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 8, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Mar 3, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 2, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 28, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of
disorders and diseases of the central nervous system;
pharmaceutical preparations for the prevention and treatment of
oncologic disorders and diseases, and psychiatric disorders and
diseases; pharmaceutical preparations for the prevention and
treatment of cancer; pharmaceutical preparations for the prevention
and treatment of disorders and diseases of the urogenital system;
pharmaceutical preparations for hereditary diseases; biologic
preparations for medical and therapeutic purposes, namely, cells for
medical or clinical use
First Use Anywhere:
Apr 1, 2022
First Use in Commerce:
Jan 10, 2024
Class 044
Providing medical information; Provision of health information
First Use Anywhere:
Apr 1, 2022
First Use in Commerce:
Apr 1, 2022
Additional Information
Design Mark
The mark consists of four lines crossing to form a diamond-shaped design.
Classification
International Classes
005
044